
Release Date: December 8, 2008 Expiration Date: December 31, 2009
Program Description A comprehensive and compassionate approach is required to care for patients with Multiple Sclerosis. While there is no cure for Multiple Sclerosis, effective symptom management can greatly enhance quality of life. Long-term success is dependent on the early detection of symptoms and the development of a comprehensive care plan. This may be achieved with a combination of pharmacologic therapies, supportive services, and referral to specialists when necessary. In this program, our esteemed faculty discuss the benefits of a multidisciplinary care team consisting of neurologists, nurses, physiatrists, psychiatrists, physical therapists, occupational therapists, and speech therapists. This program focuses on the signs and symptoms of multiple sclerosis, its affect on quality of life, and current pharmacologic and rehabilitation treatment options. The program also contains an interesting case study. Webcast Accreditation & Credit Designation ArcMesa Educators is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. ArcMesa Educators designates this educational activity for a maximum of 1 AMA PRA Category 1 credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity. ArcMesa Educators is accredited by the Accreditation Council for Pharmacy Education as a Provider of continuing pharmacy education. (UPN 200-000-08-003-H01-P). Pharmacists will receive up to 1 contact hour (0.1 CEU) for successful completion of this activity. ArcMesa Educators is an approved provider of continuing education in nursing by ASNA, an accredited approver by the ANCC Commission on Accreditation. (ANCC AL #5-85). Nurses will receive up to 1 contact hour (0.1 CEU) for successful completion of this activity. How to Receive Credit By reviewing the course content and successfully completing the post-test and evaluation, physicians are entitled to receive 1 AMA PRA category 1 credit™, nurses and pharmacists will receive 1 contact hour. Statement of credit will be available to print from your user history page. Educational Objectives At the conclusion of this activity, participants will be able to: - Identify the major symptoms associated with multiple sclerosis and illustrate how they can negatively impact the quality of life of patients with this disease.
- Examine the pharmacologic and non-pharmacologic therapies available for the treatment of multiple sclerosis-related symptoms.
- Design individualized treatment plans for patients with multiple sclerosis.
- Construct a plan for the development of an interdisciplinary care team within the practice community for the management of patients with multiple sclerosis.
Target Audience This activity is intended for primary care physicians, neurologists, psychiatrists, case managers, physical therapists, occupational therapists, neurology nurses, and pharmacists who treat patients with multiple sclerosis. Faculty Disclosures Francois Bethoux, MD Research/Grant Support: Acorda Therapeutics and Medtronic Consultant: Allergan and Medtronic Speaker Honorarium: Allergan, Biogen Idec, Medtronic and Teva Susan E. Bennett, PT, EdD, NCS Speaker Honorarium: Acorda Therapeutics Patricia Kennedy, RN, CNP, MSCN Clinical Consultant: Bayer, Biogen Idec, Serono/Pfizer and Teva Neuroscience Advisory Board: Bayer, Serono/Pfizer and Teva Neuroscience Speaker Honorarium: Serono/Pfizer and Teva Neuroscience Randall T. Schapiro, MD Research/Grant Support: Acorda Therapeutics, Bayer and Serono Advisor/Consultant: Acorda Therapeutics, Bayer, Serono and Teva Speaker Honorarium: Acorda Therapeutics, Bayer, Serono and Teva Staff Disclosure Declarations The employees of ArcMesa Educators have no financial relationships to disclose. Disclosure Policy It is the policy of ArcMesa Educators that our staff and faculty disclose real or apparent conflicts of interest relating to the topics of this educational activity, and also disclose discussions of unlabeled/unapproved uses of drugs or devices during presentations. Individuals who refuse to disclose will be disqualified from all aspects of this CME activity. ArcMesa Educators has policies in place that will identify and resolve all conflicts of interest prior to this educational activity. Acknowledgement of Sponsor Sponsored by ArcMesa Educators. Acknowledgement of Commercial Support Supported by an educational grant from Acorda Therapeutics. Disclaimer ©2008 ArcMesa Educators. All rights reserved. None of the contents may be reproduced in any form without prior written permission from ArcMesa Educators. The views and opinions expressed in this activity are those of the faculty. They do not reflect the views of Acorda Therapeutics, any other manufacturer of pharmaceuticals, ArcMesa Educators. The recommendations made in this program are based upon a combination of randomized clinical trials, current guidelines, and the clinical practice experience of the participating faculty. Any medications, diagnostic procedures or treatments discussed by the faculty should not be utilized without evaluation of their patient’s conditions. Participants are urged to consult the full prescribing information on any drug mentioned in this activity for recommended dosage, indications, contraindications, warnings, precautions, and adverse effects before prescribing any medication. Hardware/Software Requirements System Requirement: Windows 98, ME, 2000, XP, Vista; Mac OS X. Windows: Intel Pentium II 450 mhz or faster processor (or equivalent), 128MB of RAM. Mac: PowerPC G3 500mhz or faster processor, 128MB of RAM. Internet/Network: Broadband connectivity. ArcMesa Educators requires Microsoft Internet Explorer 5.5, Firefox 1.x, Netscape 7.x, Opera 7.11, Safari 1.x or later. Certain educational activities may require additional software to view multimedia, presentation or printable versions of their content. That software may be: Adobe Flash Player 8, Apple Quicktime, Adobe Acrobat, Microsoft Powerpoint, Windows Media Player, and Real Networks Real One Player.
Click here to view the program Date Created: January 9, 2009 Last Update: January 9, 2009
|